Welcome to our dedicated page for Waystar Holding SEC filings (Ticker: WAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare payment platforms like Waystar generate disclosures packed with reimbursement rules, payer-mix tables, and subscription revenue details—information investors need yet struggle to find quickly. If you have ever searched for Waystar insider trading Form 4 transactions or wondered how to decode the company’s deferred revenue footnotes, you know the challenge.
Stock Titan solves this problem by pairing real-time EDGAR feeds with AI that turns complex jargon into clear insights. From a single dashboard you can:
- Track Waystar Form 4 insider transactions real-time and spot buying or selling before material events.
- Dive into each Waystar quarterly earnings report 10-Q filing with concise AI annotations on churn, average revenue per client, and regulatory exposure.
- Skim an AI-generated brief of the Waystar annual report 10-K simplified to understand revenue-cycle market share, cloud migration costs, and cybersecurity risks.
- Receive alerts when a Waystar 8-K material events explained post details new payer contracts or leadership changes.
Still asking, “How do I read Waystar’s proxy statement executive compensation?” or “Can I get a Waystar earnings report filing analysis without sifting through 200 pages?” Our platform answers both by extracting equity-based pay data and key performance metrics into digestible summaries. Whether you are monitoring Waystar executive stock transactions Form 4, comparing subscription growth across quarters, or simply understanding Waystar SEC documents with AI, Stock Titan equips you to make informed decisions faster.
Waystar Holding Corp. (WAY) – Form 4 filing
CEO & Director Matthew J. Hawkins reported a 1 Aug 2025 transaction involving vested stock options with a $4.14 exercise price and 1 Nov 2027 expiry. Exactly 156,865 options were moved from a 2024 grantor-retained annuity trust (GRAT) to his direct account, coded “J,” which signals a change in form of ownership rather than a sale or purchase. The executive’s pecuniary interest is unchanged.
Post-transaction, Hawkins holds 1,336,412 options directly and 593,135 options indirectly (343,135 in the 2024 GRAT and 250,000 in a 2025 GRAT), totalling 1,929,547 options on common stock. No open-market trading, cash proceeds or equity dilution occurred. The filing therefore has limited immediate market impact but underscores the CEO’s large, fully-vested, below-market option stake, which continues to align his incentives with shareholders.
Waystar Holding (WAY) filed a routine Form 4 for Chief Business Officer Eric L. Sinclair III. On 06/25/2025 he exercised 9,702 options at $4.14 (Code M) and immediately sold 9,702 shares at a weighted-average $40.2243 under a 10b5-1 plan adopted 02/19/2025.
The sale is valued at roughly $391 k, represents ~2 % of his 500,572-share position, and leaves him with 490,870 shares (including unvested RSUs). No other material changes were disclosed.
FAQ
What is the current stock price of Waystar Holding (WAY)?
What is the market cap of Waystar Holding (WAY)?
